Janet Dillione - 02 Dec 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Janet Dillione
Issuer symbol
CRMD
Transactions as of
02 Dec 2025
Net transactions value
-$281,768
Form type
4
Filing time
04 Dec 2025, 21:30:28 UTC
Previous filing
26 Nov 2025
Next filing
11 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dillione Janet Director C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Janet Dillione 04 Dec 2025 0001489798

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $49,206 +12,210 +25% $4.03 60,683 02 Dec 2025 Direct
transaction CRMD Common Stock Options Exercise $66,999 +15,124 +25% $4.43 75,807 02 Dec 2025 Direct
transaction CRMD Common Stock Options Exercise $68,597 +19,323 +25% $3.55 95,130 02 Dec 2025 Direct
transaction CRMD Common Stock Sale $466,570 -46,657 -49% $10.00 48,473 02 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -12,210 -100% $0.000000 0 02 Dec 2025 Common Stock 12,210 $4.03 Direct F1
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -15,124 -100% $0.000000 0 02 Dec 2025 Common Stock 15,124 $4.43 Direct F2
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -19,323 -79% $0.000000 5,000 02 Dec 2025 Common Stock 19,323 $3.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These options were granted on 02/22/2022. These options are fully vested.
F2 These options were granted on 01/14/2023. These options are fully vested.
F3 These options were granted on 03/05/2024. These options are fully vested.